InspireMD, Inc.
NSPR
$2.53
-$0.06-2.32%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.27% | 0.24% | -12.47% | -30.10% | -4.38% |
| Total Depreciation and Amortization | 7.14% | 6.06% | -4.35% | 13.11% | 5.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.93% | -14.71% | 2.03% | 88.72% | -13.02% |
| Change in Net Operating Assets | 1,780.00% | -102.04% | 275.00% | -311.76% | 67.70% |
| Cash from Operations | -18.42% | -30.91% | 14.02% | -21.24% | -3.31% |
| Capital Expenditure | 26.13% | 11.37% | -143.59% | 9.30% | -123.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 255.42% | -192.01% | 19.33% | 2,747.73% | -97.28% |
| Cash from Investing | 239.13% | -207.59% | 14.30% | 13,480.56% | -100.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 261.97% | -105.40% | -- | -- | -- |
| Foreign Exchange rate Adjustments | 95.45% | 320.00% | -150.00% | -128.57% | 128.57% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.65% | -166.16% | 7,668.13% | 94.02% | -283.04% |